Mobile health lifestyle intervention program leads to clinically significant loss of body weight in patients with NASH.
Jonathan G StineGloriany RivasBreianna HummerAndrés Duarte-RojoChristine N MayNathaniel R GeyerVernon M ChinchilliDavid E ConroyEllen Siobhan MitchellMeaghan McCallumAndreas MichealidesKathryn H SchmitzPublished in: Hepatology communications (2023)
This clinical trial demonstrated that NW is not only feasible, acceptable, and safe but also highly efficacious because this mHealth lifestyle intervention program led to significantly greater body weight loss than standard clinical care. Future large-scale studies are required to validate these findings with more representative samples and to determine if mHealth lifestyle intervention programs can lead to sustained, long-term weight loss in patients with NASH.
Keyphrases
- weight loss
- bariatric surgery
- randomized controlled trial
- body weight
- quality improvement
- roux en y gastric bypass
- clinical trial
- gastric bypass
- metabolic syndrome
- physical activity
- cardiovascular disease
- healthcare
- public health
- weight gain
- palliative care
- glycemic control
- study protocol
- obese patients
- pain management
- case control
- skeletal muscle
- insulin resistance